Baseline And Early Post-Infusion Biomarkers Associated With Optimal Response To Idecabtagene Vicleucel (Ide-Cel) In The Karmma-3 Study Of Triple-Class-Exposed Relapsed And Refractory Multiple Myeloma
Idecabtagene Vicleucel
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Baseline And Early Post-Infusion Biomarkers Associated With Optimal Response To Idecabtagene Vicleucel (Ide-Cel) In The Karmma-3 Study Of Triple-Class-Exposed Relapsed And Refractory Multiple Myeloma ### Output: Idecabtagene Vicleucel